ARDS (MODERATE OR SEVERE)
Clinical trials for ARDS (MODERATE OR SEVERE) explained in plain language.
Never miss a new study
Get alerted when new ARDS (MODERATE OR SEVERE) trials appear
Sign up with your email to follow new studies for ARDS (MODERATE OR SEVERE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled therapy for severe lung failure enters first human tests
Disease control Not yet recruitingThis early-stage study tests a single inhaled dose of a lab-made protein (rhKGF-2) in 24 adults with moderate-to-severe ARDS who are on a breathing machine. The main goal is to see if the drug is safe and tolerable, while also checking for signs it might improve oxygen levels. Pa…
Matched conditions: ARDS (MODERATE OR SEVERE)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
Can a gas save lungs? new trial tests nitric oxide for ARDS survival
Disease control Not yet recruitingThis study tests whether adding inhaled nitric oxide (iNO) to standard care can help adults with moderate-to-severe acute respiratory distress syndrome (ARDS) live longer. About 536 participants will be randomly assigned to receive iNO or a placebo through their ventilator. The m…
Matched conditions: ARDS (MODERATE OR SEVERE)
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New ventilation method aims to shield heart in severe pneumonia
Disease control Not yet recruitingThis study tests a new way to use a breathing machine to protect the right side of the heart in patients with severe pneumonia and lung injury. About 180 adults will be assigned to either the new method or the standard one. The goal is to see if the new approach reduces heart com…
Matched conditions: ARDS (MODERATE OR SEVERE)
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC